AbbVie Target price 2024 - Analyst rating & recommendation
AbbVie Classifications & Recommendation:
AbbVie Price Target
| Target Price | $184.01 |
| Price | $167.25 |
| Potential |
10.02%
register free of charge
|
| Number of Estimates | 26 |
|
26 Analysts have issued a price target AbbVie 2025 .
The average AbbVie target price is $184.01.
This is
10.02%
register free of charge
$207.00
23.77%
register free of charge
$170.00
1.64%
register free of charge
|
|
| A rating was issued by 29 analysts: 20 Analysts recommend AbbVie to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AbbVie stock has an average upside potential 2025 of
10.02%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Billion $ | 54.32 | 55.20 |
| 6.44% | 1.63% | |
| EBITDA Margin | 49.30% | 47.90% |
| 7.88% | 2.84% | |
| Net Margin | 8.84% | 16.38% |
| 56.15% | 85.25% |
25 Analysts have issued a sales forecast AbbVie 2024 . The average AbbVie sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an AbbVie EBITDA forecast 2024. The average AbbVie EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 AbbVie Analysts have issued a net profit forecast 2024. The average AbbVie net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 2.72 | 5.12 |
| 58.97% | 88.24% | |
| P/E | 32.66 | |
| EV/Sales | 6.36 |
11 Analysts have issued a AbbVie forecast for earnings per share. The average AbbVie <a href=/blog/eps>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the AbbVie stock is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of
This results in the following potential growth metrics and future valuations:
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
